Table 1 Literature review of reported cases of mitotically active cellular fibroma
Immunohistochemistry | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author(s) | Age (y) | Size (cm) | PD | Rupture | Adhesion | Surgery | Mitoses (MF/10 HRP) | Ki-67 PI | Vimentin | SMA | α-inhibin | Calretinin | EMA | Prognosis |
Kaku et al. [11] | 32 | 6.6 × 6.0 × 4.4 | OT | – | – | LSO | 17 | 50 | + | + | ND | ND | ND | 12 month NED |
Bucella et al. [12] | 65 | 10.0 (First) | OT | – | – | TAH, BSO | 4 | 9 | + | ND | Focal+ | ND | ND | Recurrence twice NED |
12.0 (Second) | ||||||||||||||
8.0 (Third) | ||||||||||||||
Monteiro et al. [13] | 13 | 19.0 × 15.0 × 12.0 | OT | – | Omentum | RSO, OMT | 5–7 | ND | ND | ND | ND | ND | ND | 36 month NED |
Wu et al. [14] | 76 | 9.0 × 6.0 × 5.0 | PM | – | – | TAH, BSO | 5–9 | >10 | + | ND | + | – | – | ND |
Zong et al. [15] | 39 | 10.0 × 7.0 × 4.0 | OT | + | Left latum & uterus | TAH, LSO, OMT, AD, LD | 3–5 | 10 | + | + | ND | ND | – | 66 month NED |
Yamada et al. [16] | 36 | 6.0 | OT | ND | – | LS (RSO) | 10 | 8.7 | + | ND | Focal+ | – | – | 6 month NED |
Present case | 44 | 5.9 (First) | Myoma | – | – | LS (First), TAH, LSO, OMT (Second) | 6.7 | 9.5 | + | + | Focal+ | – | – | 26 month NED |
11.0 (Second) | ||||||||||||||